Ranking Profile - Chinook Therapeutics Inc

Introduction

Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. It's pipeline products include atrasentan, ADU-S100 for multiple tumors, CHK-336 for idiopathic hyperoxaluria among others. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators and B-select monoclonal antibodies to create immunotherapies for the treatment of cancers, infectious and autoimmune diseases. Its products are under development and are intended for the treatment of variety of cancers, including metastatic colorectal, multiple myeloma cancers, solid tumors and lymphomas. The company collaborates with various pharmaceutical companies to expand its products and technology platforms. It has an operational presence in The Netherlands. Chinook is headquartered in Berkeley, California, the US.